MXPA02004993A - Agent for treating hepatitis c containing ukrain. - Google Patents

Agent for treating hepatitis c containing ukrain.

Info

Publication number
MXPA02004993A
MXPA02004993A MXPA02004993A MXPA02004993A MXPA02004993A MX PA02004993 A MXPA02004993 A MX PA02004993A MX PA02004993 A MXPA02004993 A MX PA02004993A MX PA02004993 A MXPA02004993 A MX PA02004993A MX PA02004993 A MXPA02004993 A MX PA02004993A
Authority
MX
Mexico
Prior art keywords
ukrain
agent
treating hepatitis
hepatitis
treating
Prior art date
Application number
MXPA02004993A
Other languages
Spanish (es)
Inventor
Wassyl Nowicky
Original Assignee
Nowicky Wassili
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nowicky Wassili filed Critical Nowicky Wassili
Publication of MXPA02004993A publication Critical patent/MXPA02004993A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MXPA02004993A 2000-03-22 2001-03-20 Agent for treating hepatitis c containing ukrain. MXPA02004993A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0048100A AT408719B (en) 2000-03-22 2000-03-22 AGENT FOR TREATING HEPATITIS C
PCT/AT2001/000076 WO2001070203A2 (en) 2000-03-22 2001-03-20 Agent for treating hepatitis c containing ukrain

Publications (1)

Publication Number Publication Date
MXPA02004993A true MXPA02004993A (en) 2003-10-14

Family

ID=3674939

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02004993A MXPA02004993A (en) 2000-03-22 2001-03-20 Agent for treating hepatitis c containing ukrain.

Country Status (17)

Country Link
JP (1) JP2003527414A (en)
KR (1) KR20020087045A (en)
CN (1) CN1416347A (en)
AT (1) AT408719B (en)
AU (1) AU2001239000A1 (en)
BG (1) BG107088A (en)
BR (1) BR0107211A (en)
CA (1) CA2389173A1 (en)
EA (1) EA200200584A1 (en)
HR (1) HRP20020367A2 (en)
IL (1) IL149314A0 (en)
IS (1) IS6360A (en)
MA (1) MA25509A1 (en)
MX (1) MXPA02004993A (en)
NO (1) NO20022253D0 (en)
PL (1) PL365000A1 (en)
WO (1) WO2001070203A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH695417A5 (en) * 2001-11-15 2006-05-15 Ddr Wassyl Nowicky Dipl Ing Process for reacting alkaloids.
EP1459753A1 (en) 2003-03-18 2004-09-22 Nowicky, Wassyl, Dipl.-Ing. DDr. Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in the manufacture of medicaments
WO2008039179A1 (en) * 2006-09-26 2008-04-03 Addiction Research Institute, Inc. Compositions for the treatment of hepatitis c and methods for using compositions for the treatment of hepatitis c
CN106343303A (en) * 2015-07-13 2017-01-25 张如安 Beverage for killing hepatitis B virus
CN106109538A (en) * 2016-07-29 2016-11-16 桂林淮安天然保健品开发有限公司 The pharmaceutical composition for the treatment of hepatitis C

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3128018A1 (en) * 1981-07-13 1983-04-07 Wassyl 1060 Wien Nowicky "METHOD FOR DIAGNOSTICING AND FOR THE THERAPEUTIC TREATMENT OF TUMORS AND / OR INFECTIOUS DISEASES OF DIFFERENT TYPES WITH PREPARATIVE USE OF ALKALOID COMPOUNDS OR THEIR SALTS"
US4816462A (en) * 1982-05-18 1989-03-28 Nowicky Wassili Method for diagnosing and for the therapeutic treatment of tumors and/or infectious diseases of different types with alkaloid-compounds
US4970212A (en) * 1982-05-18 1990-11-13 Nowicky Wassili Method of treating human illnesses which compromise the ability to mount an effective immunological response
PT93772A (en) * 1989-04-17 1991-01-08 Searle & Co PROCESS FOR THE PREPARATION OF COMPOSITIONS FOR THE TREATMENT OF NEOPLASMS, CONTAINING AN ANTI-NEOPLASTIC AGENT, FOR EXAMPLE DOXORUBICIN AND A PROTEIN AGENT TO REDUCE THE SIDE EFFECTS, FOR EXAMPLE CARBETIMER

Also Published As

Publication number Publication date
IL149314A0 (en) 2002-11-10
NO20022253L (en) 2002-05-10
PL365000A1 (en) 2004-12-27
AT408719B (en) 2002-02-25
CN1416347A (en) 2003-05-07
ATA4812000A (en) 2001-07-15
JP2003527414A (en) 2003-09-16
HRP20020367A2 (en) 2004-02-29
NO20022253D0 (en) 2002-05-10
KR20020087045A (en) 2002-11-21
EA200200584A1 (en) 2003-06-26
AU2001239000A1 (en) 2001-10-03
BG107088A (en) 2003-05-30
WO2001070203A2 (en) 2001-09-27
WO2001070203A3 (en) 2002-09-06
CA2389173A1 (en) 2001-09-27
BR0107211A (en) 2004-01-06
IS6360A (en) 2002-04-24
MA25509A1 (en) 2002-07-01

Similar Documents

Publication Publication Date Title
HK1039947A1 (en) Hepatitis c inhibitor peptides.
GB2382892B (en) Method for quantum computing
EP1346724A4 (en) Remedies for hepatitis c
HK1058788A1 (en) Chemical compounds.
ZA200206768B (en) Aryl fused azapolycyclic compounds.
AU4699701A (en) Chemical compounds
AU2222802A (en) Chemical compounds
ZA200300447B (en) Granulation process.
ZA997026B (en) Parting agent.
HK1059254A1 (en) Acylacetonitrile compound, process for preparationthereof, and miticide containing the same.
ZA200205528B (en) Glyburide composition.
MXPA03000874A (en) Chemical compounds.
ZA200108968B (en) New compounds.
ZA200300743B (en) DDS compound and process for the preparation thereof.
AP2000001871A0 (en) Chemical agent for stabilizing soil
GB9802022D0 (en) Complexing agents
ZA991841B (en) Chemical Compounds.
EG24462A (en) Compounds for treating fundic disaccomodation
ZA200108623B (en) Process for preparing imidachloprid.
ZA200102833B (en) Organosilicon compounds.
MXPA02004993A (en) Agent for treating hepatitis c containing ukrain.
ZA991032B (en) Chemical compounds.
MXPA03005569A (en) New process.
AU138774S (en) Distiller
HK1042291A1 (en) Dimeric compounds.